Lymphoma and Chronic Lymphocytic Leukemia: Updates in Management

This CME course, which took place in April 2022, addressed the rapidly changing landscape in the management and treatment of non-Hodgkin lymphoma, Hodgkin lymphoma, and chronic lymphocytic leukemia. Through presentations by expert thought leaders reviewing the most current data and three panel discussions divided into aggressive lymphomas, indolent lymphomas, and Hodgkin lymphoma/chronic lymphocytic leukemia, participants discussed optimal management and learned the most critical updates in these diseases.


Welcome

Austin Kim, MD, gives the opening remarks for the Lymphoma and Chronic Lymphocytic Leukemia: Updates in Management symposium.
Austin Kim, MD

Austin Kim, MD

Medical Oncology

Diffuse Large B-cell Lymphoma: 22 Update

Adam Olszewski, MD, shares updates on Diffuse large B-cell lymphoma.
Adam Olszewski, MD

Adam Olszewski, MD

Hematology/Oncology

Updates on Management of Peripheral T-cell Lymphomas

Samuel Ng, MD, PhD, gives updates on the management of Peripheral T-cell lymphomas.
Samuel Ng, MD, PhD

Samuel Ng, MD, PhD

Medical Oncology

Aggressive Lymphoma Panel Discussion

Austin Kim, MD, Matthew Weinstock, MD, Adam Olszewski, MD, David Fisher, MD, and Samuel Ng, MD, PhD, take audience questions and further discuss aggressive lymphomas in this panel discussion.
Austin Kim, MD

Austin Kim, MD

Medical Oncology
Matthew Weinstock, MD

Matthew Weinstock, MD

Hematology, Medical Oncology
Adam Olszewski, MD

Adam Olszewski, MD

Hematology/Oncology
David Fisher, MD

David Fisher, MD

Medical Oncology
Samuel Ng, MD, PhD

Samuel Ng, MD, PhD

Medical Oncology


Treating Lymphoma in the Older Adult Population

Patrick Johnson, MD, discusses treating lymphoma in the older adult population.
Patrick Johnson, MD

Patrick Johnson, MD

Hematology/Oncology

Mantle Cell Lymphoma

Austin Kim, MD, discusses Mantle cell lymphoma and the current treatments, as well as where treatment is going.
Austin Kim, MD

Austin Kim, MD

Medical Oncology

CAR-T Cell Therapy for Lymphoma: Updates and Progress

Caron Jacobson, MD, MMSc, gives updates and shares progress with CAR-T cell therapy for lymphoma.
Caron Jacobson, MD, MMSc

Caron Jacobson, MD, MMSc

Medical Oncology

Elderly Indolent Lymphoma CAR-T Cell Panel Discussion

Austin Kim, MD, Philippe Armand, MD, PhD, and Patrick Johnson, MD, take audience questions and discuss cases of elderly indolent lymphoma CAR-T cell therapy in this panel discussion.
Austin Kim, MD

Austin Kim, MD

Medical Oncology
Philippe Armand, MD, PhD

Philippe Armand, MD, PhD

Medical Oncology
Patrick Johnson, MD

Patrick Johnson, MD

Hematology/Oncology

Hodgkin Lymphoma

Ann LaCasce, MD, MMSc, discusses Hodgkin lymphoma and how to approach the different types of Hodgkin patients.
Ann LaCasce, MD, MMSc

Ann LaCasce, MD, MMSc

Medical Oncology

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Inhye Ahn, MD, discusses the background and management of chronic lymphocytic leukemia and small lymphocytic lymphoma.
Inhye Ahn, MD

Inhye Ahn, MD

Medical Oncology

cHL and CLL SLL Panel Discussion and Conclusion

In this video, the panel takes audience questions and discusses cases of Classical Hodgkin Lymphoma, Chronic Lymphocutic Leukemia, and Small Lymphocytic Lymphoma.
Philippe Armand, MD, PhD

Philippe Armand, MD, PhD

Medical Oncology
Austin Kim, MD

Austin Kim, MD

Medical Oncology
Oreofe Odejide, MD, MPH

Oreofe Odejide, MD, MPH

Medical Oncology
Ann LaCasce, MD, MMSc

Ann LaCasce, MD, MMSc

Medical Oncology
Erin Parry, MD, PhD

Erin Parry, MD, PhD

Medical Oncology
Inhye Ahn, MD

Inhye Ahn, MD

Medical Oncology